The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance ...

Dr Conall Watson, a consultant epidemiologist at UK Health Security Agency (UKHSA) says: “The vaccine in the UK programmes is made by Pfizer and contains antigens against the two RSV subtypes ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Researchers found that vaccine effectiveness was 80% and 81% against RSV-associated hospitalizations and against RSV-associated critical illness among 28,271 hospitalizations for RSV-like illness ...

Consult with your health care provider before choosing a vaccine option. The CDC recommends a one-time RSV vaccine for ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

But which ones should you get? This year marks the second season for the new respiratory syncytial virus vaccine (RSV) for ...

In 2025, eligible pregnant women will be able to receive the respiratory syncytial virus (RSV) vaccine for free under the ...

The federal government will place RSV vaccines on the national immunisation program, as 12,000 babies are hospitalised with ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

This year, there are more options for those most susceptible to RSV, including a new vaccine and updated RSV vaccine guidance for seniors. Carina Marquez, MD, associate professor of Medicine in ...